Flourish Research Acquires Valley Clinical Trials

Flourish Research Acquires Valley Clinical Trials

Flourish Research, backed by private equity firm NMS Capital, announced its acquisition of Valley Clinical Trials, based in the Los Angeles suburb of Northridge, California. The financial terms of the transaction were not disclosed.  Valley Clinical Trials is a leading clinical research site with three locations in California that specialize in cardiology, metabolic and related therapeutic areas. Since its founding in 2010, Valley has rapidly grown into a leading multi-site clinical trials company serving a broad and diverse population of patients in Los Angeles County.  Launched in 2021. Flourish Research is a clinical trial site network. The company has sites throughout... Read More »
Montecito Medical Acquires Tucson, Arizona MOB

Montecito Medical Acquires Tucson, Arizona MOB

Montecito Medical Real Estate announced on September 21 the acquisition of a 14,000-square-foot medical office building (MOB) in Tucson, Arizona for an undisclosed price. The acquisition of the property expands Montecito Medical’s existing footprint in Arizona.  The property is fully occupied by Arizona Urology Specialists, the region’s premier urology practice, serving patients at 10 medical offices throughout Phoenix, Scottsdale, Glendale and Mesa, Arizona. The group uses the MOB property to deliver a variety of urology-related services. The building includes specialized space that houses a Linear Accelerator and CT scanner.  Montecito Medical specializes in... Read More »
New Harbor Capital Builds Out Clinical Research Site Platform With Acquisition

New Harbor Capital Builds Out Clinical Research Site Platform With Acquisition

New Harbor Capital has acquired Monroe Biomedical Research to build out a more robust clinical research platform.  Monroe Biomedical Research is a 6,300-square-foot clinical research facility in Monroe, near Charlotte, North Carolina. Monroe Biomedical conducts clinical research studies for asthma, COPD, diabetes, hypertension, heart failure, Alzheimer’s and COVID-19.  New Harbor Capital invests in lower middle market, growth-oriented business services, healthcare and education companies. Since 2000, New Harbor has completed more than 230 investments.  Crosstree Capital Partners acted as advisor to Monroe Biomedical and helped the target identify New Harbor Capital as... Read More »
ELNA Medical Group Acquires Physimed Health Group

ELNA Medical Group Acquires Physimed Health Group

ELNA Medical Group, one of Canada’s largest integrated networks of medical clinics, has announced its acquisition of Physimed Health Group. Established in 1988, Physimed Health Group was Quebec’s first medical network to offer continuous access to healthcare services 365 days a year.  Situated in the Saint-Laurent borough of Montreal, Physimed boasts a state-of-the-art facility spanning 45,000 square feet. It offers access to a complete range of medical services with a team of more than 50 physicians, including a public family medicine practice with Family Medicine Group status, specialty care, comprehensive medical esthetics and corporate and executive medicine. ... Read More »
Montecito Medical Acquires Medical Office Property in Milwaukee MSA

Montecito Medical Acquires Medical Office Property in Milwaukee MSA

Montecito Medical announced on September 19 its acquisition of The Lincoln Avenue Health Center building in West Allis, Wisconsin. The acquisition of the property expands Montecito Medical’s footprint in the Milwaukee MSA. Financial terms of the deal were not disclosed.  The Lincoln Avenue Health Center is a 12,600-square-foot medical office building (MOB). The building is 100% leased to Medical College of Wisconsin, a market-dominant group in the Greater Milwaukee area.  Montecito Medical Real Estate specializes in healthcare-related real estate acquisitions and funding. Since 2006, it has completed transactions across the United States involving more than $5.1 billion in... Read More »
SK Pharmteco Acquires Controlling Interest in Center for Breakthrough Medicines

SK Pharmteco Acquires Controlling Interest in Center for Breakthrough Medicines

SK Pharmteco, a division of South Korean conglomerate SK Inc., has acquired a controlling interest in the Center for Breakthrough Medicines.  The Center for Breakthrough Medicines is a King of Prussia, Pennsylvania-based contract development and manufacturing organization (CDMO) specializing in cell and gene therapy.  SK Pharmteco is based in Rancho Cordova, California. The company specializes in the production of active pharmaceutical ingredients, advanced intermediates and cell and gene therapy for the pharmaceutical industry.  SK Inc., the investment arm of SK Group in Seoul, previously invested $350 million in the Center for Breakthrough Medicines in December 2021. The... Read More »